Trials / Unknown
UnknownNCT03140319
Transplantation of Fibroblast for Correction of Nasolabial Folds
Autologous Transplantation of Cultured Fibroblast for Correction of Nasolabial Folds
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- SCARM Institute, Tabriz, Iran · Other Government
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study evaluated the safety and efficacy of the Autologous cultured fibroblast for correction of Nasolabial folds and inhibition of skin aging
Detailed description
Autologous cultured fibroblast which is obtain from the patient's normal skin is harvested and expanded in an in vitro. Biopsies samples are obtained from the behind of the patient's ear as a source of fibroblasts, then fibroblast cells isolated and expanded through cell culture, and used for the correction of Nasolabial folds, deep wrinkles of the forehead. Prior to final packaging, cell viability is assessed to be at least 85%
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fibroblast | Transplantation of 20 million cell by three injection |
| BIOLOGICAL | Placebo | Injection of Placebo |
Timeline
- Start date
- 2020-12-10
- Primary completion
- 2021-11-15
- Completion
- 2021-12-26
- First posted
- 2017-05-04
- Last updated
- 2020-10-27
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT03140319. Inclusion in this directory is not an endorsement.